JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M102790200 on August 28, 2001

J. Biol. Chem., Vol. 276, Issue 46, 42645-42657, November 16, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/46/42645    most recent
M102790200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiltfang, J.
Right arrow Articles by Saftig, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiltfang, J.
Right arrow Articles by Saftig, P.

Elevation of beta -Amyloid Peptide 2-42 in Sporadic and Familial Alzheimer's Disease and Its Generation in PS1 Knockout Cells*

Jens Wiltfangabcd, Hermann Esselmannac, Philippe Cuperse, Manuela Neumannf, Hans Kretzschmarf, Michael Beyermanng, Detlev Schleuderh, Holger Jahni, Eckart Rüthera, Johannes Kornhuberbj, Wim Annaerte, Bart De Stroopere, and Paul Saftigk

From the a Department of Psychiatry, Molecular Neurobiology, and k Department of Biochemistry II, University of Göttingen, D-37073 Göttingen, Germany, e Center for Human Genetics, Neuronal Cell Biology Group, Flanders Interuniversity Institute for Biotechnology and Catholic University of Leuven, B-3000 Leuven, Belgium, f Institute for Neuropathology, Ludwig-Maximilians-Universität, D-81377 Munich, Germany, g Research Institute of Molecular Pharmacology, D-13125 Berlin, Germany, h Institute for Medical Physics and Biophysics, University of Münster, D-48129 Münster, Germany, i Department of Psychiatry, University of Hamburg, D-20246 Hamburg, Germany, and j Department of Psychiatry, University of Erlangen, D-91054 Erlangen, Germany

Urea-based beta -amyloid (Abeta ) SDS-polyacrylamide gel electrophoresis and immunoblots were used to analyze the generation of Abeta peptides in conditioned medium from primary mouse neurons and a neuroglioma cell line, as well as in human cerebrospinal fluid. A comparable and highly conserved pattern of Abeta peptides, namely, 1-40/42 and carboxyl-terminal-truncated 1-37, 1-38, and 1-39, was found. Besides Abeta 1-42, we also observed a consistent elevation of amino-terminal-truncated Abeta 2-42 in a detergent-soluble pool in brains of subjects with Alzheimer's disease. Abeta 2-42 was also specifically elevated in cerebrospinal fluid samples of Alzheimer's disease patients. To decipher the contribution of potential different gamma -secretases (presenilins (PSs)) in generating the amino-terminal- and carboxyl-terminal-truncated Abeta peptides, we overexpressed beta -amyloid precursor protein (APP)-trafficking mutants in PS1+/+ and PS1-/- neurons. As compared with APP-WT (primary neurons from control or PS1-deficient mice infected with Semliki Forest virus), PS1-/- neurons and PS1+/+ neurons overexpressing APP-Delta ct (a slow-internalizing mutant) show a decrease of all secreted Abeta peptide species, as expected, because this mutant is processed mainly by alpha -secretase. This drop is even more pronounced for the APP-KK construct (APP mutant carrying an endoplasmic reticulum retention motif). Surprisingly, Abeta 2-42 is significantly less affected in PS1-/- neurons and in neurons transfected with the endocytosis-deficient APP-Delta ct construct. Our data confirm that PS1 is closely involved in the production of Abeta 1-40/42 and the carboxyl-terminal-truncated Abeta 1-37, Abeta 1-38, and Abeta 1-39, but the amino-terminal-truncated and carboxyl-terminal-elongated Abeta 2-42 seems to be less affected by PS1 deficiency. Moreover, our results indicate that the latter Abeta peptide species could be generated by a beta Asp/Ala-secretase activity.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

b Supported by a grant from the VerUm Foundation (Munich, Germany).

c Both authors contributed equally to this work.

d To whom correspondence should be addressed: Dept. of Psychiatry, Molecular Neurobiology, University of Göttingen, D-37073 Göttingen, Germany. E-mail: jwiltfa@gwdg.de.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
FASEB J.Home page
W.-P. Chang, D. Downs, X.-P. Huang, H. Da, K.-M. Fung, and J. Tang
Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization
FASEB J, October 1, 2007; 21(12): 3184 - 3196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Watzlawik, L. Skora, D. Frense, C. Griesinger, M. Zweckstetter, W. J. Schulz-Schaeffer, and M. L. Kramer
Prion Protein Helix1 Promotes Aggregation but Is Not Converted into beta-Sheet.
J. Biol. Chem., October 6, 2006; 281(40): 30242 - 30250.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Tolia, L. Chavez-Gutierrez, and B. De Strooper
Contribution of Presenilin Transmembrane Domains 6 and 7 to a Water-containing Cavity in the {gamma}-Secretase Complex
J. Biol. Chem., September 15, 2006; 281(37): 27633 - 27642.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Bibl, B. Mollenhauer, H. Esselmann, P. Lewczuk, H.-W. Klafki, K. Sparbier, A. Smirnov, L. Cepek, C. Trenkwalder, E. Ruther, et al.
CSF amyloid-{beta}-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
Brain, May 1, 2006; 129(5): 1177 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. Lewczuk, G. Beck, H. Esselmann, R. Bruckmoser, R. Zimmermann, M. Fiszer, M. Bibl, J. M. Maler, J. Kornhuber, and J. Wiltfang
Effect of Sample Collection Tubes on Cerebrospinal Fluid Concentrations of Tau Proteins and Amyloid {beta} Peptides
Clin. Chem., February 1, 2006; 52(2): 332 - 334.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Vanderstichele, G. De Meyer, N. Andreasen, V. Kostanjevecki, A. Wallin, A. Olsson, K. Blennow, and E. Vanmechelen
Amino-Truncated {beta}-Amyloid42 Peptides in Cerebrospinal Fluid and Prediction of Progression of Mild Cognitive Impairment
Clin. Chem., September 1, 2005; 51(9): 1650 - 1660.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Pitsi and J.-N. Octave
Presenilin 1 Stabilizes the C-terminal Fragment of the Amyloid Precursor Protein Independently of {gamma}-Secretase Activity
J. Biol. Chem., June 11, 2004; 279(24): 25333 - 25338.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. G. Bazan and W. J. Lukiw
Cyclooxygenase-2 and Presenilin-1 Gene Expression Induced by Interleukin-1beta and Amyloid beta 42 Peptide Is Potentiated by Hypoxia in Primary Human Neural Cells
J. Biol. Chem., August 9, 2002; 277(33): 30359 - 30367.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.